<DOC>
	<DOCNO>NCT00705081</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability low-density lipoprotein-cholesterol ( LDL-C ) lower Indonesian population treat ezetimibe co-administered statin routine daily practice . In addition , study investigate whether extent target level set participate doctor achieve co-administration therapy .</brief_summary>
	<brief_title>Evaluation LDL-C Lowering Effects Ezetimibe Achieved Co-administration Therapy With Statins Indonesian Population ( Study P04276 ) ( COMPLETED )</brief_title>
	<detailed_description>Sampling method : invitation physician 's patient .</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>All subject receive ezetimibe 10 mg prescribe daily practice</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>